FABP5 and synovial sarcoma: Employing the proteome analysis of human saliva, Baldini et al. initially reported a highly significant difference in the FABP5 expression in primary SS patients compared with healthy volunteers, raising the possibility that FABP5 might have uses as a specific marker that reflects the disease activity and/or severity [4].